AC
Applied Clinical Trials
ACT Brief: Trial Simulations and Protocol Risk, RBQM Financial Value Quantified, and Three Drug Approvals
0:00-1:51
In today's ACT Brief, we examine what AI simulations surface in trial design, how RBQM delivers measurable financial returns, and three new FDA-approved treatments across hair loss, movement disorder, and bone disease.
Publisher
Applied Clinical Trials
Link
audioboom.com/posts/8958038
Published
September 29, 2026
Duration
2 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
AC
Applied Clinical Trials
@appliedclinicaltrials
#trialsimulations #rbqmfinancialvalue #drugapprovals #lifesciences
